001     257684
005     20250411153447.0
024 7 _ |a 10.1016/j.cbpa.2023.102304
|2 doi
024 7 _ |a pmid:37068388
|2 pmid
024 7 _ |a 1367-5931
|2 ISSN
024 7 _ |a 1879-0402
|2 ISSN
024 7 _ |a altmetric:146024470
|2 altmetric
037 _ _ |a DZNE-2023-00481
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Ramirez, Lisa Marie
|0 P:(DE-2719)9001275
|b 0
|e First author
|u dzne
245 _ _ |a Molecular-level interplay between intrinsically disordered clients and Hsp90.
260 _ _ |a London
|c 2023
|b Current Biology Ltd.
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1744378448_5312
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Proteostasis is maintained by a network of molecular chaperones, a prominent member of which is the 90-kilodalton heat shock protein Hsp90. The chaperone function of Hsp90 has been extensively reviewed previously, emphasizing its ATPase activity and remodeling of folded client proteins. Experimental evidence implicating Hsp90 in neurodegenerative diseases has bolstered interest in the noncanonical chaperoning of intrinsically disordered protein (IDPs), however the interplay between Hsp90 and its disordered clients remains poorly understood. In this review we describe recent advances that have contributed to our understanding of the intricate mechanisms characterizing Hsp90-mediated chaperoning of the IDPs tau and α-synuclein and survey emerging insights into the modulation of the chaperone-client interplay in the context of neurodegeneration.
536 _ _ |a 352 - Disease Mechanisms (POF4-352)
|0 G:(DE-HGF)POF4-352
|c POF4-352
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a α-Synuclein
|2 Other
650 _ 7 |a α-Synuclein
|2 Other
650 _ 7 |a Alzheimer's disease
|2 Other
650 _ 7 |a Heat shock protein
|2 Other
650 _ 7 |a Hsp90
|2 Other
650 _ 7 |a Structure
|2 Other
650 _ 7 |a Tau
|2 Other
650 _ 7 |a α-Synuclein
|2 Other
650 _ 7 |a HSP90 Heat-Shock Proteins
|2 NLM Chemicals
650 _ 7 |a Molecular Chaperones
|2 NLM Chemicals
650 _ 7 |a Intrinsically Disordered Proteins
|2 NLM Chemicals
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a HSP90 Heat-Shock Proteins: metabolism
|2 MeSH
650 _ 2 |a Molecular Chaperones
|2 MeSH
650 _ 2 |a Proteostasis
|2 MeSH
650 _ 2 |a Intrinsically Disordered Proteins: metabolism
|2 MeSH
650 _ 2 |a Neurodegenerative Diseases
|2 MeSH
700 1 _ |a Zweckstetter, Markus
|0 P:(DE-2719)2810591
|b 1
|e Last author
|u dzne
773 _ _ |a 10.1016/j.cbpa.2023.102304
|g Vol. 74, p. 102304 -
|0 PERI:(DE-600)2019216-2
|p 102304
|t Current opinion in chemical biology
|v 74
|y 2023
|x 1367-5931
856 4 _ |u https://www.sciencedirect.com/science/article/abs/pii/S136759312300042X?via%3Dihub
856 4 _ |u https://pub.dzne.de/record/257684/files/DZNE-2023-00481_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/257684/files/DZNE-2023-00481_Restricted.pdf?subformat=pdfa
|x pdfa
909 C O |p VDB
|o oai:pub.dzne.de:257684
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)9001275
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2810591
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-352
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms
|x 0
914 1 _ |y 2023
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2022-11-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-16
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-10-22
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1120
|2 StatID
|b BIOSIS Reviews Reports And Meetings
|d 2023-10-22
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CURR OPIN CHEM BIOL : 2022
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-22
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-22
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b CURR OPIN CHEM BIOL : 2022
|d 2023-10-22
920 1 _ |0 I:(DE-2719)1410001
|k AG Zweckstetter
|l Translational Structural Biology
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1410001
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21